Danaher Corporation: Business Overview, Financials & Competitive Analysis
Danaher Corporation scores 8/10 on the AskCyborg Cyborg Score (Strong). Danaher benefits from durable biologics tailwinds and consumables-driven recurring revenue with margin expansion upside as life sciences markets normalize. Underlying biologic demand has grown at double-digit rates annually for over a decade and is expected to continue into 2026, with robust FDA approvals for biologic medicines in 2025 driving global.
What is Danaher Corporation's industry? Danaher Corporation (danaher.com) operates in Life Sciences, Diagnostics & Biotechnology Equipment Manufacturing. AskCyborg classifies Danaher Corporation under Life Sciences, Diagnostics & Biotechnology Equipment Manufacturing in its company registry.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services globally, operating through Biotechnology, Life Sciences, and Diagnostics segments. The comp...
Cyborg Score thesis
Danaher benefits from durable biologics tailwinds and consumables-driven recurring revenue with margin expansion upside as life...
Read the full analyst-debate transcript →Get the Latest Danaher Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeDanaher Corporation Overview
Pro stress-test →Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services globally, operating through Biotechnology, Life Sciences, and Diagnostics segments. The company delivered strong Q4 2025 results with better-than-expected performance across its portfolio, exceeding margin, earnings, and cash flow expectations.
Strategic Profile
Pro stress-test →The combination of a differentiated portfolio, the Danaher Business System, and a strong balance sheet positions Danaher for long-term value creation. Growth is supported primarily by consumables tied to commercial biologics production, with approximately three-quarters of bioprocessing revenue linked to commercial manufacturing volumes benefiting from strong monoclonal antibody production.
Competitive Landscape
Pro stress-test →Top competitors include Boston Scientific, Medtronic, and Fujifilm. Danaher operates in life sciences and diagnostics where it competes against larger diversified medical device manufacturers and specialized instrument makers. The company's integrated Danaher Business System and consumables-focused business model provide competitive advantages in recurring revenue generation.
Industry Context
Danaher Corporation operates in Life Sciences, Diagnostics & Biotechnology Equipment Manufacturing.
Key facts
Founded: 1969 · Headquarters: Washington, DC, US · Employees: 50,000 · Revenue: $23.9B · Market cap: $165B